Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
Authors
Keywords
-
Journal
npj Vaccines
Volume 6, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-10
DOI
10.1038/s41541-021-00285-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance
- (2020) Kimberly M. Cirelli et al. CELL
- Engineered immunogen binding to alum adjuvant enhances humoral immunity
- (2020) Tyson J. Moyer et al. NATURE MEDICINE
- Env Exceptionalism: Why Are HIV-1 Env Glycoproteins Atypical Immunogens?
- (2020) P.J. Klasse et al. Cell Host & Microbe
- Vulnerabilities in coronavirus glycan shields despite extensive glycosylation
- (2020) Yasunori Watanabe et al. Nature Communications
- Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens
- (2020) Aleksandar Antanasijevic et al. PLoS Pathogens
- Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens
- (2020) George Ueda et al. eLife
- Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulations
- (2020) Jacob T. Martin et al. npj Vaccines
- Self-assembling influenza nanoparticle vaccines drive extended germinal center activity and memory B cell maturation
- (2020) Hannah G. Kelly et al. JCI Insight
- Multifaceted Effects of Antigen Valency on B Cell Response Composition and Differentiation In Vivo
- (2020) Yu Kato et al. IMMUNITY
- Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates
- (2020) Christopher A. Cottrell et al. PLoS Pathogens
- Immunological basis for enhanced immunity of nanoparticle vaccines
- (2019) Hannah G Kelly et al. Expert Review of Vaccines
- Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus
- (2019) Jessica Marcandalli et al. CELL
- Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization
- (2019) Rui Kong et al. CELL
- Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence
- (2019) Kwinten Sliepen et al. Nature Communications
- Nanoparticle Vaccines for Inducing HIV-1 Neutralizing Antibodies
- (2019) Mitch Brinkkemper et al. Vaccines
- Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability
- (2019) Viktoriya Dubrovskaya et al. IMMUNITY
- A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses
- (2019) Jon M. Steichen et al. SCIENCE
- Multiple roles for HIV broadly neutralizing antibodies
- (2019) Barton F. Haynes et al. Science Translational Medicine
- Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle
- (2019) Philip J. M. Brouwer et al. Nature Communications
- Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens
- (2018) Robert K. Abbott et al. IMMUNITY
- Explanations for the high potency of HPV prophylactic vaccines
- (2018) John Schiller et al. VACCINE
- Neutralization tiers of HIV-1
- (2018) David C. Montefiori et al. Current Opinion in HIV and AIDS
- Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers
- (2018) Talar Tokatlian et al. SCIENCE
- Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes
- (2018) Talar Tokatlian et al. Scientific Reports
- Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization Breadth
- (2018) Kshitij Wagh et al. Cell Reports
- New tools for automated high-resolution cryo-EM structure determination in RELION-3
- (2018) Jasenko Zivanov et al. eLife
- A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure
- (2017) Jeong Hyun Lee et al. IMMUNITY
- Particulate Array of Well-Ordered HIV Clade C Env Trimers Elicits Neutralizing Antibodies that Display a Unique V2 Cap Approach
- (2017) Paola Martinez-Murillo et al. IMMUNITY
- Glycine Substitution at Helix-to-Coil Transitions Facilitates the Structural Determination of a Stabilized Subtype C HIV Envelope Glycoprotein
- (2017) Javier Guenaga et al. IMMUNITY
- Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem
- (2017) Colin Havenar-Daughton et al. IMMUNOLOGICAL REVIEWS
- Native-like Env trimers as a platform for HIV-1 vaccine design
- (2017) Rogier W. Sanders et al. IMMUNOLOGICAL REVIEWS
- Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo
- (2017) Max Medina-Ramírez et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Covalent Linkage of HIV-1 Trimers to Synthetic Liposomes Elicits Improved B Cell and Antibody Responses
- (2017) Shridhar Bale et al. JOURNAL OF VIROLOGY
- Developing an HIV vaccine
- (2017) Barton F. Haynes et al. SCIENCE
- Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization
- (2017) Alba Torrents de la Peña et al. Cell Reports
- Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
- (2016) Dennis R. Burton et al. Annual Review of Immunology
- HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies
- (2016) Jon M. Steichen et al. IMMUNITY
- Beyond antigens and adjuvants: formulating future vaccines
- (2016) Tyson J. Moyer et al. JOURNAL OF CLINICAL INVESTIGATION
- Accurate design of megadalton-scale two-component icosahedral protein complexes
- (2016) J. B. Bale et al. SCIENCE
- Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein
- (2016) Anna-Janina Behrens et al. Cell Reports
- Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies
- (2016) Laura E. McCoy et al. Cell Reports
- Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes
- (2015) Steven W. de Taeye et al. CELL
- Structure-Guided Redesign Increases the Propensity of HIV Env To Generate Highly Stable Soluble Trimers
- (2015) Javier Guenaga et al. JOURNAL OF VIROLOGY
- Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity
- (2015) Kwinten Sliepen et al. Retrovirology
- HIV-1 neutralizing antibodies induced by native-like envelope trimers
- (2015) R. W. Sanders et al. SCIENCE
- Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies
- (2014) A. T. McGuire et al. SCIENCE
- Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
- (2013) Masaru Kanekiyo et al. NATURE
- Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction
- (2012) J. J. Moon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Appion: An integrated, database-driven pipeline to facilitate EM image processing
- (2009) Gabriel C. Lander et al. JOURNAL OF STRUCTURAL BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started